Overview

Our AFP SPEAR T-cell is aimed at the treatment of patients with hepatocellular (liver) cancer. A Phase I study is now open for enrollment.

Pipeline

Program Indications Pre-Clinical Phase I/II Registration
AFP Hepatocellular
Pre-Clinical Phase complete
Phase I/II Phase in progress
Registration Phase not started